These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4526220)

  • 1. Prolongation of the life-span in mice adapted to large amounts of L-dopa.
    Cotzias GC; Miller ST; Nicholson AR; Maston WH; Tang LC
    Proc Natl Acad Sci U S A; 1974 Jun; 71(6):2466-9. PubMed ID: 4526220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa, fertility, and longevity.
    Cotzias GC; Miller ST; Tang LC; Papavasiliou PS
    Science; 1977 Apr; 196(4289):549-51. PubMed ID: 850799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo.
    Fujita K; Ito S; Inoue S; Yamamoto Y; Takeuchi J; Shamoto M; Nagatsu T
    Cancer Res; 1980 Jul; 40(7):2543-6. PubMed ID: 6771000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A; Bartholini G; Gey KF; Jenni A
    Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
    [No Abstract]   [Full Text] [Related]  

  • 5. Aberrant CpG Methylation Mediates Abnormal Transcription of MAO-A Induced by Acute and Chronic L-3,4-Dihydroxyphenylalanine Administration in SH-SY5Y Neuronal Cells.
    Yang Z; Wang X; Yang J; Sun M; Wang Y; Wang X
    Neurotox Res; 2017 Apr; 31(3):334-347. PubMed ID: 27981510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-dopa and REM sleep in normal and mentally retarded subjects.
    Castaldo V; Krynicki VE; Crade M
    Biol Psychiatry; 1973 Jun; 6(3):295-9. PubMed ID: 4354507
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha1-adrenoceptors mediate dihydroxyphenylalanine-induced activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaques.
    Visanji NP; Fox SH; Johnston TH; Millan MJ; Brotchie JM
    J Pharmacol Exp Ther; 2009 Jan; 328(1):276-83. PubMed ID: 18955589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinsonian syndromes. Treatment by association of L-dopa plus decarboxylase inhibitor.
    Gauthier G; Juge O; Birchler A
    Eur Neurol; 1974; 11(3):133-57. PubMed ID: 4839098
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association].
    Wajsbort J; Hemli JA; Alfandary I; Yahel M; Siegfried J
    Wien Med Wochenschr; 1971 Oct; 121(42):741-5. PubMed ID: 5115985
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement in mono-manual dexterity in parkinsonism when supplementing levodopa with an extracerebral decarboxylase inhibitor, RO 4-4602.
    Knutsson E; Mårtensson A
    Scand J Rehabil Med; 1974; 6(2):89-93. PubMed ID: 4837060
    [No Abstract]   [Full Text] [Related]  

  • 11. Decrease of the 3,4-dihydroxyphenylalanine (DOPA) decarboxylase activities in human erythrocytes and mouse tissues after administration of DOPA.
    Tate SS; Sweet R; McDowell FH; Meister A
    Proc Natl Acad Sci U S A; 1971 Sep; 68(9):2121-3. PubMed ID: 5289372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-dopa and behavior.
    Psychopharmacol Bull; 1971 Jul; 7(3):41-3. PubMed ID: 5000747
    [No Abstract]   [Full Text] [Related]  

  • 13. A scatter-jump syndrome with gnawing and fighting induced by L-dopa in mice.
    Bryson G; Bischoff F
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):469-76. PubMed ID: 5167776
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
    Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reciprocal exclusion by L-dopa (L-3,4-dihydroxyphenylalanine) and L-tyrosine of their incorporation as single units into a soluble rat brain protein.
    Rodriguez JA; Barra HS; Arce CA; Hallak ME; Caputto R
    Biochem J; 1975 Jul; 149(1):115-21. PubMed ID: 1191253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gamma-Glutamyl dopa: a kidney-specific dopamine precursor.
    Wilk S; Mizoguchi H; Orlowski M
    J Pharmacol Exp Ther; 1978 Jul; 206(1):227-32. PubMed ID: 660553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Effect of acute and chronic treatment with L-dopa on catecholamine turnover.
    Yamanaka Y; Kono S
    Jpn J Pharmacol; 1974; 24(0):s:24. PubMed ID: 4545736
    [No Abstract]   [Full Text] [Related]  

  • 18. L-dopa, dopamine, and hypomania.
    Murphy DL; Goodwin FK; Brodie HK; Bunney WE
    Am J Psychiatry; 1973 Jan; 130(1):79-82. PubMed ID: 4682751
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the effects of reversible and irreversible inhibitors of aromatic L-amino acid decarboxylase on the half-life and other pharmacokinetic parameters of oral L-3,4-dihydroxyphenylalanine.
    Huebert ND; Palfreyman MG; Haegele KD
    Drug Metab Dispos; 1983; 11(3):195-200. PubMed ID: 6135575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acute administration of L-dopa on body temperature in man.
    Boyd AE; Mager M; Angoff G; Lebovitz HE
    J Appl Physiol; 1974 Nov; 37(5):675-8. PubMed ID: 4436192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.